A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting

Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult. Objective: This study was designed to develop a treatment tolerability index algorithm that combines AE reporti...

Full description

Bibliographic Details
Main Authors: Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry, Lene Hammer-Helmich, Djamel A. Zighed, Adrian Tanasescu, Mondher Toumi
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Adverse event
antipsychotic
schizophrenia
standardization
tolerability index
Online Access:http://dx.doi.org/10.1080/20016689.2017.1372026

Internet

http://dx.doi.org/10.1080/20016689.2017.1372026

Similar Items